These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 30896529)

  • 1. Identifying Drug Repurposing Opportunities in Oncology.
    Orecchioni S; Roma S; Raimondi S; Gandini S; Bertolini F
    Cancer J; 2019; 25(2):82-87. PubMed ID: 30896529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug repurposing in oncology--patient and health systems opportunities.
    Bertolini F; Sukhatme VP; Bouche G
    Nat Rev Clin Oncol; 2015 Dec; 12(12):732-42. PubMed ID: 26483297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computer-aided drug repurposing for cancer therapy: Approaches and opportunities to challenge anticancer targets.
    Mottini C; Napolitano F; Li Z; Gao X; Cardone L
    Semin Cancer Biol; 2021 Jan; 68():59-74. PubMed ID: 31562957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug Repurposing in Oncology, an Attractive Opportunity for Novel Combinatorial Regimens.
    Falvo P; Orecchioni S; Roma S; Raveane A; Bertolini F
    Curr Med Chem; 2021; 28(11):2114-2136. PubMed ID: 33109033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repurposing Drugs in Oncology: Next Steps.
    Verbaanderd C; Meheus L; Huys I; Pantziarka P
    Trends Cancer; 2017 Aug; 3(8):543-546. PubMed ID: 28780930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug repurposing: a promising tool to accelerate the drug discovery process.
    Parvathaneni V; Kulkarni NS; Muth A; Gupta V
    Drug Discov Today; 2019 Oct; 24(10):2076-2085. PubMed ID: 31238113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Silico Oncology Drug Repositioning and Polypharmacology.
    Cheng F
    Methods Mol Biol; 2019; 1878():243-261. PubMed ID: 30378081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug Repurposing in Anticancer Reagent Development.
    Chen PC; Liu X; Lin Y
    Comb Chem High Throughput Screen; 2017; 20(5):395-402. PubMed ID: 28025934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Old wine in new bottles: Drug repurposing in oncology.
    Antoszczak M; Markowska A; Markowska J; Huczyński A
    Eur J Pharmacol; 2020 Jan; 866():172784. PubMed ID: 31730760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug repurposing for cancer therapy, easier said than done.
    Gonzalez-Fierro A; Dueñas-González A
    Semin Cancer Biol; 2021 Jan; 68():123-131. PubMed ID: 31877340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptome Signature Reversion as a Method to Reposition Drugs Against Cancer for Precision Oncology.
    Koudijs KKM; Terwisscha van Scheltinga AGT; Böhringer S; Schimmel KJM; Guchelaar HJ
    Cancer J; 2019; 25(2):116-120. PubMed ID: 30896533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can Drug Repurposing Accelerate Precision Oncology?
    Schipper LJ; Zeverijn LJ; Garnett MJ; Voest EE
    Cancer Discov; 2022 Jul; 12(7):1634-1641. PubMed ID: 35642948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A medicinal chemistry perspective of drug repositioning: Recent advances and challenges in drug discovery.
    Pillaiyar T; Meenakshisundaram S; Manickam M; Sankaranarayanan M
    Eur J Med Chem; 2020 Jun; 195():112275. PubMed ID: 32283298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug repurposing in oncology: Compounds, pathways, phenotypes and computational approaches for colorectal cancer.
    Nowak-Sliwinska P; Scapozza L; Ruiz i Altaba A
    Biochim Biophys Acta Rev Cancer; 2019 Apr; 1871(2):434-454. PubMed ID: 31034926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug repurposing from the perspective of pharmaceutical companies.
    Cha Y; Erez T; Reynolds IJ; Kumar D; Ross J; Koytiger G; Kusko R; Zeskind B; Risso S; Kagan E; Papapetropoulos S; Grossman I; Laifenfeld D
    Br J Pharmacol; 2018 Jan; 175(2):168-180. PubMed ID: 28369768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repurposing existing therapeutics, its importance in oncology drug development: Kinases as a potential target.
    Islam S; Wang S; Bowden N; Martin J; Head R
    Br J Clin Pharmacol; 2022 Jan; 88(1):64-74. PubMed ID: 34192364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revisiting Repurposing.
    Sharlow ER
    Assay Drug Dev Technol; 2016 Dec; 14(10):554-556. PubMed ID: 27982703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repurposing of drugs: An attractive pharmacological strategy for cancer therapeutics.
    Kirtonia A; Gala K; Fernandes SG; Pandya G; Pandey AK; Sethi G; Khattar E; Garg M
    Semin Cancer Biol; 2021 Jan; 68():258-278. PubMed ID: 32380233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into Computational Drug Repurposing for Neurodegenerative Disease.
    Paranjpe MD; Taubes A; Sirota M
    Trends Pharmacol Sci; 2019 Aug; 40(8):565-576. PubMed ID: 31326236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Web-based Tools for Drug Repurposing: Successful Examples of Collaborative Research.
    Vanhaelen Q
    Curr Med Chem; 2021; 28(1):181-195. PubMed ID: 32003659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.